In vivo near-infrared fluorescence imaging of integrin

The overexpression of integrin a2b1 has been demonstrated to correlate with prostate tumor aggressiveness and metastatic potential. Recently, we reported that the DGEA peptide is a promising targeting ligand for near-infrared fluorescence and microPET imaging of integrin a2b1 expression in prostate can-cers. Here, we aimed to further improve the targeting efficacy of this peptide by incorporating a series of cell-penetrating pep-tides (CPPs) into the DGEA sequence. Methods: After the con-jugation with appropriate fluorescent dyes, the CPP-DGEA peptides were evaluated in human prostate cell lines (PC-3, CWR-22, and LNCaP) that contain different integrin a2b1 expression levels. In addition, to reduce excess kidney uptake, a carboxypeptidase-specific sequence Gly-Lys was incorpo-rated into the probe design, allowing for cleavage by the kidney brush border enzymes of the CPP before uptake by proximal tubule cells. Results: Although the CPP motif greatly facilitated the translocation of CPP-DGEA without affecting binding spe-cificity in vitro, fluorescent dye–labeled CPP-DGEA demonstra-ted extremely high kidney uptake in vivo. Kidney uptake was dramatically decreased after a carboxypeptidase-specific pep-tide linker (Gly-Lys) had been incorporated into the probe design. The optimized probe demonstrated a prominent accu-mulation of activity in PC-3 tumor (integrin a2b1–positive). Receptor specificity was confirmed with blocking experiments and evaluation in a CWR-22 control tumor model with low a2b1 expression. Conclusion: This study demonstrated that the introduction of a CPP sequence can facilitate the internalization of an integrin-targeted peptide probe in vitro. Moreover, a cleav-able peptide linker successfully reduced kidney uptake while preserving good tumor uptake in vivo. Key Words: prostate cancer; integrin a2b1; cell penetrating peptides; prognostic marke